R C Duvoisin, R Katz. Show Affiliations »
Abstract
Entities: Chemical Disease Species
Mesh: See more » AgedAtaxia/chemically inducedAtaxia/drug therapyCentral Nervous System Diseases/chemically inducedCentral Nervous System Diseases/drug therapyChildCognition Disorders/chemically inducedCognition Disorders/drug therapyDelirium/chemically inducedDelirium/drug therapyFemaleHallucinations/chemically inducedHallucinations/drug therapyHumansMaleMiddle AgedNeostigmine/adverse effectsParasympatholytics/adverse effectsParkinson Disease/drug therapyPhysostigmine/therapeutic usePreanesthetic MedicationScopolamine/adverse effectsSpeech Disorders/chemically inducedSpeech Disorders/drug therapyTrihexyphenidyl/adverse effects
Substances: See more » ParasympatholyticsNeostigmineTrihexyphenidylPhysostigmineScopolamine
Year: 1968 PMID: 5755090
Source DB: PubMed Journal: JAMA ISSN: 0098-7484 Impact factor: 56.272